from Reuters: Health News https://reut.rs/2QQUsLG
Wednesday, 26 December 2018
U.S. drug developer Capricor places Duchenne drug trial on hold
Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy (DMD), a muscle-wasting disorder, citing a safety review.
from Reuters: Health News https://reut.rs/2QQUsLG
from Reuters: Health News https://reut.rs/2QQUsLG
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment